Alto Neuroscience Inc.
ANRO | NYSE
$30.54
-$0.09 (-0.29%)
Sep 22, 2026, 2:24 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -27.64M | -26.24M | -16.18M | -14.18M | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M | -8.66M | -7.28M | -7.65M |
Depreciation & Amortization | 184K | 184K | 157K | 164K | 169K | 171K | 170K | 135K | 113K | 97K | 92K | 63K | 112K | 86K | 97K |
Stock-Based Compensation | 3.55M | 2.82M | n/a | 2.19M | 2.01M | 1.97M | 1.57M | 2M | 1.89M | 2.18M | 606K | 541K | 1.26M | 484K | 941K |
Other Working Capital | 2.99M | -5.88M | 2.4M | 836K | 972K | -4.39M | 861K | 2.38M | 1.68M | -1.38M | -375K | 1.18M | -906K | -290K | -605K |
Other Non-Cash Items | 498K | 531K | 2.41M | 613K | 458K | 1.13M | 345K | 138K | 905K | 413K | 151K | -62K | 56K | 166K | -225K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.64M | -4.39M | 2.1M | 1.3M | 1.3M | -4.66M | 99K | 2.79M | 1.43M | -255K | -1.16M | 834K | 600K | -976K | 818K |
Operating Cash Flow | -19.76M | -27.09M | -11.52M | -9.92M | -13.78M | -16.56M | -13.02M | -11.73M | -11.69M | -10.98M | -11.52M | -7.77M | -6.64M | -7.52M | -6.02M |
Capital Expenditures | n/a | -556K | n/a | n/a | n/a | -24K | -506K | -1.01M | -340K | -224K | -352K | -43K | -54K | -21K | -62K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -556K | n/a | n/a | n/a | -24K | -506K | -1.01M | -340K | -224K | -352K | -43K | -54K | -21K | -62K |
Debt Repayment | n/a | n/a | n/a | 750K | 750K | 9.48M | n/a | 1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 4.88M | n/a | -167K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 114.78M | -190K | n/a | -597K | 419K | -546K | n/a | n/a | n/a | -3.02M | -1.9M | 109K | 43K | n/a | 9.67M |
Financial Cash Flow | -273K | 114.94M | 50.19M | 153K | 613K | 9.13M | 49K | 1.32M | -234K | 134.56M | 43.13M | 49K | -51K | 25M | 19.71M |
Net Cash Flow | -20.03M | 87.28M | 38.67M | -9.77M | -13.17M | -7.48M | -13.47M | -11.42M | -12.27M | 123.35M | 31.26M | -7.74M | -6.75M | 17.44M | 13.65M |
Free Cash Flow | -19.76M | -27.65M | -11.52M | -9.92M | -13.78M | -16.58M | -13.53M | -12.73M | -12.03M | -11.21M | -11.88M | -7.81M | -6.69M | -7.55M | -6.08M |
Adj. Free Cash Flow | -23.31M | -30.47M | -11.52M | -12.11M | -15.78M | -18.55M | -15.09M | -14.73M | -13.92M | -13.39M | -12.48M | -8.35M | -7.95M | -8.03M | -7.02M |
Maintenance CapEx | n/a | -184K | n/a | n/a | n/a | -24K | -506K | -1.01M | -340K | -224K | -352K | -43K | -54K | -21K | -62K |
Growth CapEx | n/a | -372K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -19.76M | -27.28M | -11.52M | -9.92M | -13.78M | -16.58M | -13.53M | -12.73M | -12.03M | -11.21M | -11.88M | -7.81M | -6.69M | -7.55M | -6.08M |
Add to Watchlist
Select watchlists to add or remove ANRO